Page last updated: 2024-08-24

meglumine antimoniate and prednisone

meglumine antimoniate has been researched along with prednisone in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's4 (66.67)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Blanc, AP; Jacquème, P; Magnan, A; Poirier, R; Redding, E; Sudan, N1
Arruda, D; Foss, NT; Motta, AC; Souza, CS1
Garcia-Cordoba, F; Gonzalez Diaz, G; Ortuño, FJ; Segovia, M1
Avallone, L; Ciaramella, P; Cortese, L; Di Loria, A; Lombardi, P; Mastellone, V; Pelagalli, A; Piantedosi, D1
Akrout, R; Baklouti, S; Fourati, H; Hachicha, I; Hdiji, N; Sellami, M1
Ayadi, N; Béji, M; Bouomrani, S; Farah, A1

Reviews

1 review(s) available for meglumine antimoniate and prednisone

ArticleYear
[Visceral leishmaniasis associated with Hodgkin's disease: diagnostic difficulties].
    Revue de pneumologie clinique, 1991, Volume: 47, Issue:4

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Antiprotozoal Agents; Bleomycin; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Immunocompromised Host; Leishmaniasis, Visceral; Mechlorethamine; Meglumine; Meglumine Antimoniate; Opportunistic Infections; Organometallic Compounds; Prednisone; Procarbazine; Vinblastine; Vincristine

1991

Other Studies

5 other study(ies) available for meglumine antimoniate and prednisone

ArticleYear
Disseminated mucocutaneous leishmaniasis resulting from chronic use of corticosteroid.
    International journal of dermatology, 2003, Volume: 42, Issue:9

    Topics: Aged; Animals; Antiprotozoal Agents; Diagnosis, Differential; Facial Dermatoses; Humans; Immunocompromised Host; Leishmania braziliensis; Leishmaniasis, Mucocutaneous; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Prednisone; Pulmonary Disease, Chronic Obstructive

2003
Fatal visceral leishmaniasis, with massive bone-marrow infection, in an immunosuppressed but HIV-negative Spanish patient, after the initiation of treatment with meglumine antimoniate.
    Annals of tropical medicine and parasitology, 2005, Volume: 99, Issue:2

    Topics: Antiprotozoal Agents; Bone Marrow; Bone Marrow Diseases; Fatal Outcome; Glucocorticoids; HIV Seronegativity; Humans; Hypotension; Immunocompromised Host; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Prednisone; Pulmonary Disease, Chronic Obstructive

2005
The effects of prednisone on haemostasis in leishmaniotic dogs treated with meglumine antimoniate and allopurinol.
    Veterinary journal (London, England : 1997), 2008, Volume: 177, Issue:3

    Topics: Allopurinol; Animals; Antiprotozoal Agents; Dog Diseases; Dogs; Female; Homeostasis; Leishmania infantum; Leishmaniasis, Visceral; Male; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Platelet Aggregation; Prednisone; Random Allocation; Risk Assessment

2008
[Cutaneous leishmaniasis in rheumatoid arthritis].
    La Revue de medecine interne, 2009, Volume: 30, Issue:7

    Topics: Adult; Antiprotozoal Agents; Arthritis, Rheumatoid; Female; Glucocorticoids; Humans; Immunocompromised Host; Immunosuppressive Agents; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Methotrexate; Middle Aged; Organometallic Compounds; Prednisone

2009
[Bilateral chronic and granulomatous total uveitis following cutaneous leishmaniasis].
    Medecine et maladies infectieuses, 2011, Volume: 41, Issue:6

    Topics: Adolescent; Anti-Inflammatory Agents; Antiprotozoal Agents; Female; Granuloma; Humans; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Methylprednisolone; Organometallic Compounds; Panuveitis; Prednisone

2011